Scientists at Weill Cornell Medicine have developed a pipeline that will enable study of the biological roles of gut bacteria, recognized as key factors in health and disease.
A Cornell faculty member is part of a core team that has organized the Tompkins County COVID-19 Food Task Force, a nerve center working to ensure that those in need have access to food and that food producers stay in operation during the crisis.
Entitled individuals were less likely to report that they were following COVID-19 health guidelines, according to a new paper co-authored by Emily Zitek, associate professor in the ILR School.
This is the largest federal grant ever awarded to Weill Cornell Medicine and the fourth consecutive time this initiative has been funded by the NIH, representing 20 years of continuous funding.
Mycobacterium tuberculosis, the hardy bacterial species that causes tuberculosis, has an unexpected vulnerability that future drugs may be able to exploit, according to a study from researchers at Weill Cornell Medicine.
The new findings published in Science capture never-before-recorded stages of a molecular construction process, with implications for future pharmaceutical development.
Three New York state companies have been chosen to participate in the Cornell Center for Materials Research JumpStart Program, through which they will collaborate with faculty members to develop and improve their products.
According to new research out of Weill Cornell Medicine, a protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body.
Cornell's Office of Academic Integration has announced 15 new multi-investigator seed grants, including support for a project on climate change, pollen and asthma attacks and another to develop a microbial delivery system for a unique treatment of colorectal cancer.